Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 13.33
-0.08 (-0.60%)
Aug 14, 2026, 3:00 PM CST
Zhejiang Medicine Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,816 | 8,881 | 9,375 | 7,794 | 8,116 | 9,129 |
Revenue Growth | -6.03% | -5.28% | 20.29% | -3.96% | -11.10% | 24.60% |
Gross Profit Gross Profit Growth | 2,685 | 2,896 | 3,785 | 2,402 | 2,678 | 3,599 |
Operating Income Operating Income Growth | 740.78 | 859.52 | 1,291 | 7.98 | 489.74 | 1,160 |
Net Income Net Income Growth | 751.31 | 873.38 | 1,161 | 429.64 | 539.57 | 1,045 |
Earnings Per Share EPS Growth | 0.78 | 0.91 | 1.21 | 0.45 | 0.56 | 1.09 |
EPS Growth | -49.30% | -24.79% | 168.89% | -19.64% | -48.62% | 45.33% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Life Nutrition Life Nutrition Growth | 4,332 |
Medicine Medicine Growth | 4,457 |
Others Others Growth | 44.51 |
Total Total Growth | 8,834 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,240 | 3,418 | 2,261 | 1,788 | 1,885 | 2,226 |
Total Debt Total Debt Growth | 957.35 | 874.41 | 756.43 | 809.44 | 833.97 | 476.82 |
Net Cash (Debt) Net Cash Growth | 2,282 | 2,543 | 1,504 | 978.89 | 1,051 | 1,749 |
Net Cash Growth | 33.35% | 69.06% | 53.67% | -6.90% | -39.89% | 75.16% |
Net Cash Per Share Net Cash Per Share Growth | 2.39 | 2.66 | 1.57 | 1.03 | 1.09 | 1.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,681 | 1,886 | 1,223 | 634.31 | 520.6 | 1,137 |
Capital Expenditures CapEx Growth | -473.62 | -446.47 | -689.14 | -796.87 | -975.99 | -939.6 |
Free Cash Flow Free Cash Flow Growth | 1,207 | 1,439 | 534.15 | -162.56 | -455.39 | 197.05 |
Free Cash Flow Growth | 42.64% | 169.45% | - | - | - | -72.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.46% | 32.61% | 40.37% | 30.82% | 33.00% | 39.43% |
Operating Margin | 8.40% | 9.68% | 13.77% | 0.10% | 6.03% | 12.71% |
Pretax Margin | 9.12% | 10.72% | 12.93% | 4.66% | 6.05% | 12.64% |
Profit Margin | 8.52% | 9.84% | 12.38% | 5.51% | 6.65% | 11.45% |
FCF Margin | 13.69% | 16.21% | 5.70% | -2.09% | -5.61% | 2.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.280 | 0.280 | 0.370 | 0.150 | 0.170 | 0.330 |
Dividend Per Share Growth | -24.32% | -24.32% | 146.67% | -11.77% | -48.48% | 43.48% |
Dividend Yield | 2.10% | 2.07% | 2.45% | 1.49% | 1.57% | 2.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.07 | 15.04 | 13.14 | 23.93 | 20.76 | 15.66 |
Forward PE | 13.33 | 13.46 | 10.55 | 13.58 | 15.18 | 12.31 |
P/FCF Ratio | 10.47 | 9.13 | 28.55 | - | - | 83.06 |
PS Ratio | 1.43 | 1.48 | 1.63 | 1.32 | 1.38 | 1.79 |